Christopher Ray Aker, Sr. VP & General Counsel: Regulus Therapeutics RGLS Sell · Filed 24/01/18

Trade details

Type: Insider sale
Amount: $6,506.92
Shares · price: 5,468 sh · $1.19 a share
Held after: 10,056 sh
Stock: Regulus Therapeutics RGLS
Person: Christopher Ray AkerSr. VP & General Counsel
Trade date: 24/01/18
Filed: 24/01/18
Days to filing: 0 days

Sold 35.2% of holdings

Share of holding sold: 35.2%

Regulus Therapeutics trades, last 26 weeks

What else happened in Regulus Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/19~24/02/17

Christopher Ray Aker's recent trades

Christopher Ray AkerSr. VP & General Counsel
Sell10b5-1 planRegulus Therapeutics
Sell10b5-1 plan
Regulus Therapeutics
RGLS
$48.6K
38,547 sh
$48.6K
Filed 25/01/15
Traded 25/01/13
Christopher Ray AkerSr. VP & General Counsel
Sell10b5-1 planRegulus Therapeutics
Sell10b5-1 plan
Regulus Therapeutics
RGLS
$6,411
5,088 sh
$6,411
Filed 25/01/15
Traded 25/01/14